Sonova revises FY 2022/23 outlook due to subdued market and ongoing input cost challenge - Seite 2

Reflecting the current challenges and uncertainties in the remainder of the financial year, Sonova revises its outlook for FY 2022/23. The Group now expects consolidated sales to increase by 15%-19% and adjusted EBITA to grow in the range of 6%-10%, both measured at constant exchange rates. This compares to our previous outlook of growth in sales and adjusted EBITA of 17-21% and 12-18% respectively, both measured at constant exchange rates. Reflecting the recent exchange rate movements, the Group anticipates a negative impact on the reported FY 2022/23 revenues and profitability in Swiss francs.

Arnd Kaldowski, CEO of Sonova, says: “The revised outlook for FY 2022/23 implies a sound sales performance in the second half, amid an expected slowing market momentum. This demonstrates our confidence in the success of the imminent launch of our new hearing aid product platform. The new platform represents another significant step in innovation focused on improved audiological performance, further supporting our leading market position. It also reflects the typical higher seasonality of the Consumer Hearing business. Coupled with strict cost control and the positive impact from recent price increases, we expect to achieve solid profitable growth for the same period.” 
 
Investor and analyst conference call
Today at 08.30 AM CEST, Sonova will host a conference call for investors and analysts on this announcement. 

The listen-only live audio webcast can be accessed at:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=PMvoPtM ...

Participants who would like to listen in and ask questions live during the call are kindly requested to dial the following numbers 10-15 minutes prior to the start of the call:

[phone] (Europe / Switzerland)
[phone] (UK)
[phone] (USA)

– End – 

Contacts:

Investor Relations

Thomas Bernhardsgrütter
Phone    [phone]
Mobile    [phone]
Email    [e-mail]